Hydroxyl safflower yellow B combined with doxorubicin inhibits the proliferation of human breast cancer MCF-7 cells

Doxorubicin (DOX) is currently the preferred chemotherapeutic agent for breast cancer, and hydroxyl safflower yellow B (HSYB) has a tumor growth-inhibiting activity. The present study aimed to investigate the effects of HSYB combined with DOX on the proliferation of human breast cancer MCF-7 cells a...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncol Lett
Prif Awduron: Lin, Kehao, Qin, Ze, Qu, Chuanjun, Chen, Xiaoyu, Jiang, Qingling, Li, Minjing, Zheng, Qiusheng, Li, Defang
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: D.A. Spandidos 2021
Pynciau:
Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8025109/
https://ncbi.nlm.nih.gov/pubmed/33850567
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2021.12687
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg